Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting.
Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting.
复制标题
DOI：
10.1177/1363461505052660
复制
发表时间：
2005-06-01
影响因子：
2.5
通讯作者：
Yu, Shunying
中科院分区：
文献类型：
--
作者：
Chang, Doris F;Myers, Hector F;Yu, Shunying
本研究探讨了中国患者的诊断一致性，精神病学和残疾与神精帅若，ICD-10神经衰弱，和DSM-IV诊断。不明原因躯体主诉的患者（N=139）完成了DSM-III（SCID）的结构化临床访谈、简明症状量表（BSI）和简明健康调查表36（SF-36）。神精衰若可重新归类为DSM-IV未分化躯体形式障碍（30.6%）和躯体形式疼痛障碍（22.4%）;然而，44.9%的患者不符合DSM-IV核心诊断。神经衰弱与神精衰若的一致性显著（p <0.001）。症状困扰和残疾与躯体形式和焦虑症患者报告的症状相似。在中国的背景下，Shenjing Shuairuo描述了一个具有临床显著水平的障碍和残疾的异质性群体。
This study examines diagnostic concordance, symptomatology and disability among Chinese patients with shenjing shuairuo, ICD-10 neurasthenia, and DSM-IV diagnoses. Patients (N=139) with unexplained somatic complaints completed the Structured Clinical Interview for DSM-III (SCID), the Brief Symptom Inventory (BSI), and the Short Form 36 (SF-36). Shenjing shuairuo could be reclassified as DSM-IV undifferentiated somatoform disorder (30.6%) and somatoform pain disorder (22.4%); however, 44.9% did not qualify for a core DSM-IV diagnosis. Concordance of neurasthenia and shenjing shuairuo was significant (p < .001). Symptom distress and disability was similar to that reported by patients with somatoform and anxiety disorders. Within the Chinese context, shenjing shuairuo describes a heterogeneous group with clinically significant levels of disturbance and disability.